-
-
-
-
-
-
-
Realbotix Reports Financial Results for Q3-2026
-
-
-
-
-
-
-
Realbotix updates on NASDAQ listing timeline for subsidiary
-
-
-
-
-
-
-
Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors
-
-
-
-
-
-
-
Onconetix raises $12.9 million, settles debt with Veru
-
-
-
-
-
-
-
Onconetix to acquire Ocuvex Therapeutics in stock deal
-
-
-
-
-
-
-
Onconetix (ONCO) Signs LoI to Merge with Ocuvex Therapeutics
-
-
-
-
-
-
-
Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing
-
1,197,338 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


